Y Intercept Hong Kong Ltd Acquires 12,242 Shares of SPDR S&P Biotech ETF $XBI

Y Intercept Hong Kong Ltd raised its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 185.9% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 18,828 shares of the exchange traded fund’s stock after buying an additional 12,242 shares during the period. Y Intercept Hong Kong Ltd’s holdings in SPDR S&P Biotech ETF were worth $1,887,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Prime Capital Investment Advisors LLC grew its holdings in SPDR S&P Biotech ETF by 37.9% during the second quarter. Prime Capital Investment Advisors LLC now owns 9,939 shares of the exchange traded fund’s stock valued at $824,000 after purchasing an additional 2,729 shares during the period. Altfest L J & Co. Inc. lifted its position in shares of SPDR S&P Biotech ETF by 63.1% during the 3rd quarter. Altfest L J & Co. Inc. now owns 124,921 shares of the exchange traded fund’s stock valued at $12,517,000 after buying an additional 48,326 shares in the last quarter. Brian Low Financial Group LLC bought a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter valued at approximately $668,000. AlphaCore Capital LLC grew its stake in shares of SPDR S&P Biotech ETF by 6,650.0% during the 2nd quarter. AlphaCore Capital LLC now owns 540 shares of the exchange traded fund’s stock valued at $45,000 after acquiring an additional 532 shares during the period. Finally, RFG Advisory LLC purchased a new stake in SPDR S&P Biotech ETF in the 2nd quarter worth approximately $208,000.

SPDR S&P Biotech ETF Trading Up 0.6%

NYSEARCA XBI opened at $126.74 on Friday. SPDR S&P Biotech ETF has a 12 month low of $66.66 and a 12 month high of $132.09. The stock has a market cap of $8.59 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93. The company’s 50 day moving average is $123.61 and its two-hundred day moving average is $106.85.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.